Benutzer: Gast  Login
Titel:

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).

Dokumenttyp:
Journal Article
Autor(en):
Griesinger, Frank; Sebastian, Martin; Brueckl, Wolfgang M; Hummel, Horst-Dieter; Jaeschke, Bastian; Kern, Jens; Wesseler, Claas; Jänicke, Martina; Fleitz, Annette; Zacharias, Stefan; Hipper, Annette; Groth, Annika; Weichert, Wilko; Dörfel, Steffen; Petersen, Volker; Schröder, Jan; Wilke, Jochen; Eberhardt, Wilfried E E; Thomas, Michael
Abstract:
INTRODUCTION: Patients with metastatic NSCLC (mNSCLC) treated with immune checkpoint inhibitors in clinical practice may often not meet the strict inclusion criteria of clinical trials. Our aim was to assess the trial eligibility of patients with mNSCLC treated with pembrolizumab monotherapy in real-world and to compare the outcome of "trial-ineligible" and "potentially trial-eligible" patients. METHODS: Data from the prospective, clinical research platform CRISP were used to compare patient cha...     »
Zeitschriftentitel:
JTO Clin Res Rep
Jahr:
2024
Band / Volume:
5
Heft / Issue:
4
Volltext / DOI:
doi:10.1016/j.jtocrr.2023.100626
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/38586301
TUM Einrichtung:
Institut für Allgemeine Pathologie und Pathologische Anatomie (Dr. Mogler komm.)
 BibTeX